Concepedia

Mary Buckwalter

MB

12

Publications

666

Citations

12

H-Index

2004

Active since

Affiliations

Takeda (United States)(Current)

Shine Micro (United States)

Pfizer (United States)

Mary Buckwalter is an author at Takeda (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2004–2011

12

Publications

12

Population Pharmacokinetic Analysis of Dalbavancin, a Novel Lipoglycopeptide

Mary Buckwalter, James A. Dowell · The Journal of Clinical Pharmacology · 2005 · 105 citations

, , +11

Population Pharmacokinetic Analysis and Simulation of the Time‐Concentration Profile of Etanercept in Pediatric Patients With Juvenile Rheumatoid Arthritis

Dong‐Seok Yim, Honghui Zhou, Mary Buckwalter et al. · The Journal of Clinical Pharmacology · 2005 · 79 citations

Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment

Thomas Marbury, James A. Dowell, Elyse Seltzer et al. · The Journal of Clinical Pharmacology · 2009 · 74 citations

Lisdexamfetamine Dimesylate: Linear Dose‐Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open‐Label Single‐Dose Pharmacokinetic Study in Healthy Adult Volunteers

James Ermer, Robert Homolka, Patrick Martin et al. · The Journal of Clinical Pharmacology · 2010 · 73 citations

, , +16

Pharmacokinetics of dalbavancin in plasma and skin blister fluid

David P. Nicolau, Heather K. Sun, Elyse Seltzer et al. · Journal of Antimicrobial Chemotherapy · 2007 · 64 citations · Full text

Rows per page

1–5 of 12